GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,062,000 | +131.1% | 44,967 | +8.4% | 0.00% | – |
| Q2 2022 | $1,325,000 | -3.1% | 41,479 | +5.0% | 0.00% | – |
| Q1 2022 | $1,368,000 | +19.2% | 39,503 | +0.8% | 0.00% | – |
| Q4 2021 | $1,148,000 | +10.5% | 39,195 | -3.9% | 0.00% | – |
| Q3 2021 | $1,039,000 | -17.3% | 40,772 | +13.5% | 0.00% | – |
| Q2 2021 | $1,257,000 | -18.3% | 35,920 | -4.9% | 0.00% | – |
| Q1 2021 | $1,539,000 | -82.6% | 37,773 | -81.5% | 0.00% | -100.0% |
| Q4 2020 | $8,854,000 | -71.2% | 204,452 | -63.3% | 0.00% | -70.0% |
| Q3 2020 | $30,732,000 | -10.0% | 557,340 | +3.1% | 0.01% | -16.7% |
| Q2 2020 | $34,128,000 | +32.1% | 540,603 | +6.9% | 0.01% | +9.1% |
| Q1 2020 | $25,840,000 | -36.2% | 505,784 | -0.7% | 0.01% | -15.4% |
| Q4 2019 | $40,494,000 | +76.4% | 509,429 | +7.7% | 0.01% | +116.7% |
| Q3 2019 | $22,957,000 | +110.8% | 473,153 | +128.6% | 0.01% | +100.0% |
| Q2 2019 | $10,889,000 | -0.8% | 207,005 | -0.1% | 0.00% | -25.0% |
| Q1 2019 | $10,973,000 | +434.7% | 207,313 | +176.3% | 0.00% | +300.0% |
| Q2 2017 | $2,052,000 | – | 75,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |